PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-5.04%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$367M
AUM Growth
+$367M
(-6.8%)
Cap. Flow
+$41.2M
Cap. Flow
% of AUM
11.21%
Top 10 Holdings %
Top 10 Hldgs %
48.75%
Holding
121
New
27
Increased
18
Reduced
16
Closed
16
Top Buys
| 1 |
AtriCure
ATRC
|
$13.1M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$10.8M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$6.89M |
| 4 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$6.59M |
| 5 |
SI-BONE Inc
SIBN
|
$6.17M |
Top Sells
| 1 |
Grifois
GRFS
|
$13.5M |
| 2 |
AGN
Allergan plc
AGN
|
$13.3M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$7.52M |
| 4 |
CONMED
CNMD
|
$5.18M |
| 5 |
DexCom
DXCM
|
$4.82M |
Sector Composition
| 1 | Healthcare | 79.72% |
| 2 | Industrials | 2.66% |
| 3 | Consumer Staples | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ICU Medical
ICUI
$3.15B
| $25.6M | 3.04% | 126,784 +23,464 | +23% | +$4.73M |
|
2
Inspire Medical Systems
INSP
$2.77B
| $22M | 2.61% | 364,980 -18,660 | -5% | -$1.12M |
|
|
NSTG
3
DELISTED
NanoString Technologies, Inc.
NSTG
| $21.9M | 2.6% | 911,253 -53,317 | -6% | -$1.28M |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $18.7M | 2.22% | 207,996 +120,806 | +139% | +$10.8M |
|
|
INOV
5
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $18.4M | 2.18% | 1,104,040 +395,570 | +56% | +$6.59M |
|
|
VRAY
6
DELISTED
ViewRay, Inc.
VRAY
| $17.3M | 2.05% | 6,904,628 +551,689 | +9% | +$1.38M |
|
7
STAAR Surgical
STAA
$1.36B
| $15.8M | 1.87% | 488,950 -51,160 | -9% | -$1.65M |
|
|
IMDX
8
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $13.7M | 1.62% | 5,578,283 -118,293 | -2% | -$290K |
|
|
9
AtriCure
ATRC
$1.84B
| $13.1M | 1.55% | +388,994 | New | +$13.1M |
|
10
Establishment Labs
ESTA
$1.2B
| $12.7M | 1.51% | 878,227 +195,627 | +29% | +$2.83M |
|
|
IVC
11
DELISTED
Invacare Corporation
IVC
| $11.9M | 1.42% | 1,607,846 +269,353 | +20% | +$2M |
|
12
Zimmer Biomet
ZBH
$21B
| $11.2M | 1.33% | 110,852 -19,938 | -15% | -$2.02M |
|
|
13
DexCom
DXCM
$29.5B
| $10M | 1.19% | 37,183 -17,899 | -32% | -$4.82M |
|
|
RCM
14
DELISTED
R1 RCM Inc. Common Stock
RCM
| $9.76M | 1.16% | 1,073,943 +264,333 | +33% | +$2.4M |
|
|
XENT
15
DELISTED
Intersect ENT, Inc
XENT
| $8.08M | 0.96% | 681,865 -48,495 | -7% | -$575K |
|
|
XLRN
16
DELISTED
Acceleron Pharma Inc.
XLRN
| $6.89M | 0.82% | +76,681 | New | +$6.89M |
|
|
MNTA
17
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $6.7M | 0.8% | 246,214 +82,724 | +51% | +$2.25M |
|
|
QTNT
18
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $6.64M | 0.79% | 1,680,641 +590,241 | +54% | +$2.33M |
|
|
19
SI-BONE Inc
SIBN
$719M
| $6.17M | 0.73% | +516,476 | New | +$6.17M |
|
20
OrthoPediatrics
KIDS
$536M
| $5.89M | 0.7% | 148,513 -94,879 | -39% | -$3.76M |
|
21
Catalyst Pharmaceutical
CPRX
$2.52B
| $5.57M | 0.66% | +1,446,953 | New | +$5.57M |
|
22
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.48M | 0.65% | +11,212 | New | +$5.48M |
|
23
Adaptive Biotechnologies
ADPT
$2.01B
| $5.42M | 0.64% | 195,000 +140,990 | +261% | +$3.92M |
|
|
PROF
24
Profound Medical
PROF
$134M
| $5.28M | 0.63% | +542,256 | New | +$5.28M |
|
25
Twist Bioscience
TWST
$1.63B
| $5.28M | 0.63% | +172,670 | New | +$5.28M |
|